Clinical trials referenced in this document:
Funding for this research was provided by:
Helse Sør-Øst RHF (2018090, 2017100)
Bristol-Myers Squibb Foundation
Received: 18 April 2020
Accepted: 17 June 2020
First Online: 3 July 2020
Ethics approval and consent to participate
: The ICON trial has been approved by the Norwegian and Belgian Medical Agencies and Ethics Committees. The study is performed in compliance with the World Medical Association Declaration of Helsinki and ICH E6 for Good Clinical Practice. Signed informed consent is obtained from all patients.
: All authors have consented to the publication. Approval has also been obtained from BMS.
: The authors declare that they have no competing interests.